Cargando…

Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas

BACKGROUND: Stanniocalcin 2 (STC2) is overexpressed in several types of human cancers, and its overexpression positively correlates to tumor progression and poor prognosis. However, the clinical significance of STC2 overexpression in nasopharyngeal carcinomas (NPC) has not been investigated. This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shaojun, Guo, Qiaojuan, Wen, Jiangmei, Li, Chao, Lin, Jin, Cui, Xiaofei, Sang, Nianli, Pan, Jianji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015363/ https://www.ncbi.nlm.nih.gov/pubmed/24606961 http://dx.doi.org/10.1186/1756-9966-33-26

Ejemplares similares

Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
por: He, Huocong, et al.
Publicado: (2019)

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy
por: Lu, Tianzhu, et al.
Publicado: (2016)

Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
por: Xu, Yun, et al.
Publicado: (2016)

Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma
por: Xu, Yuanji, et al.
Publicado: (2017)

Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
por: Qie, Shuo, et al.
Publicado: (2022)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Suggestions for Lymph Node Classification of UICC/AJCC Staging System: A Retrospective Study Based on 1197 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiation Therapy
por: Guo, Qiaojuan, et al.
Publicado: (2015)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

The Prognosis of Nasopharyngeal Carcinoma Involving Masticatory Muscles: A Retrospective Analysis for Revising T Subclassifications
por: Xiao, Youping, et al.
Publicado: (2015)

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma
por: Lin, Cheng, et al.
Publicado: (2022)

Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients
por: Xiao, Youping, et al.
Publicado: (2015)

Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma
por: Zong, Jingfeng, et al.
Publicado: (2019)

Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
por: Guo, Qiaojuan, et al.
Publicado: (2016)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
por: Xu, Yuanji, et al.
Publicado: (2017)

SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2021)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Does MRI-Detected Cranial Nerve Involvement Affect the Prognosis of Locally Advanced Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy?
por: Zong, Jingfeng, et al.
Publicado: (2014)

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer
por: Wang, Jian, et al.
Publicado: (2018)

Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status
por: Zheng, Wei, et al.
Publicado: (2016)

Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma
por: Huang, Pei-Yu, et al.
Publicado: (2016)

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma
por: Lin, Jing, et al.
Publicado: (2022)

Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis
por: Lin, Cheng, et al.
Publicado: (2022)

Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration
por: Leung, Cherry C. T., et al.
Publicado: (2020)

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2018)

Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2019)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
por: Zhang, Yan, et al.
Publicado: (2010)

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2017)

Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum]
Publicado: (2019)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
por: Guo, Qiaojuan, et al.
Publicado: (2020)

Expression of Stanniocalcin-1 and Stanniocalcin-2 in Laryngeal Squamous Cell Carcinoma and Correlations with Clinical and Pathological Parameters
por: Zhou, Han, et al.
Publicado: (2014)

Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma
por: Li, Ji-Bin, et al.
Publicado: (2019)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Wang, Zhi-Hui, et al.
Publicado: (2020)

Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma
por: Li, Wen-Fei, et al.
Publicado: (2012)

Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases
por: Lin, Shaojun, et al.
Publicado: (2010)

Stanniocalcin-1 Overexpression Prevents Depression-Like Behaviors Through Inhibition of the ROS/NF-κB Signaling Pathway
por: Chao, Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tslcd75ijbmnm17vrmhbq1c3b